Mesalamine - NDC Database (Page 2)
0832-6056 Jun 06, 2023
Mesalamine .375 g/1 Oral Capsule, Extended Release by Upsher-smith Laboratories, LLC
Mesalamine .375 g/1 Oral Capsule, Extended Release by Upsher-smith Laboratories, LLC
31722-043 Feb 05, 2024
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Camber Pharmaceuticals, Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Camber Pharmaceuticals, Inc.
46708-724 Nov 03, 2022
Mesalamine .375 g/1 Oral Capsule, Extended Release by Alembic Pharmaceuticals Limited
Mesalamine .375 g/1 Oral Capsule, Extended Release by Alembic Pharmaceuticals Limited
51407-274 Jan 25, 2019
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Golden State Medical Supply, Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Golden State Medical Supply, Inc.
54092-100 Aug 29, 2017
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Shire Us Manufacturing Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Shire Us Manufacturing Inc.
59651-397 Mar 31, 2023
Mesalamine .375 g/1 Oral Capsule, Extended Release by Aurobindo Pharma Limited
Mesalamine .375 g/1 Oral Capsule, Extended Release by Aurobindo Pharma Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.